What is the appropriate management of anaphylactic shock?

Management of Anaphylactic Shock

Immediately administer intramuscular epinephrine 0.3-0.5 mg (1:1000 dilution) into the anterolateral thigh (vastus lateralis muscle) as soon as anaphylactic shock is recognized—this is the single most critical intervention that saves lives. 1, 2, 3

Immediate First-Line Management (First 5 Minutes)

1. Epinephrine Administration

• Route: Intramuscular injection into the mid-outer thigh (vastus lateralis) is preferred over deltoid injection—produces higher and more rapid peak plasma levels 1
• Adult dose: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) IM
• Pediatric dose: 0.01 mg/kg IM (maximum 0.3 mg in prepubertal children, 0.5 mg in adolescents) 1, 4
• Repeat every 5 minutes as needed if symptoms persist or recur 1, 2
• No absolute contraindications to epinephrine in anaphylaxis—the risk of withholding epinephrine exceeds any theoretical risk from administration 1, 3

2. Simultaneous ABC Assessment

• Airway: Assess for angioedema, stridor, or impending obstruction
• Breathing: Check for bronchospasm, wheezing, respiratory distress
• Circulation: Monitor blood pressure, pulse, signs of shock
• Position: Place patient supine with legs elevated (unless respiratory distress or vomiting present) 1, 5

3. Remove Triggering Agent

Stop all potential causative agents immediately (IV colloids, antibiotics, latex exposure) 5

Secondary Management (After Initial Epinephrine)

For Persistent Hypotension Despite Epinephrine:

1. Aggressive fluid resuscitation: 1-2 L normal saline IV rapidly in adults (5-10 mL/kg in first 5 minutes); up to 30 mL/kg in first hour for children 1

2. IV epinephrine infusion if multiple IM doses fail:

   • Prepare 1 mg epinephrine in 250 mL D5W (4 mcg/mL concentration)
   • Start at 1-4 mcg/min, titrate up to 10 mcg/min maximum 1
   • Alternative: 0.05-0.1 mg IV bolus (5-10% of cardiac arrest dose) when IV access available 2
   • Critical caveat: IV epinephrine carries risk of lethal arrhythmias—reserve for profoundly hypotensive patients who fail IM epinephrine and volume resuscitation 1

3. Refractory shock: Add dopamine 2-20 mcg/kg/min IV, titrated to blood pressure >90 mmHg systolic 1

For Persistent Bronchospasm:

• Nebulized albuterol 2.5-5 mg in 3 mL saline, repeat as necessary 1
• Administer 100% oxygen at 6-8 L/min 1

Adjunctive Medications (AFTER Epinephrine):

These are second-line only—never delay or substitute for epinephrine 1:

1. H1 antihistamine: Diphenhydramine 25-50 mg IV/IM (1-2 mg/kg in children) 1
2. H2 antihistamine: Ranitidine 1 mg/kg IV over 5 minutes (combination with H1 blocker superior to H1 alone) 1
3. Corticosteroids: Methylprednisolone 1-2 mg/kg/day IV every 6 hours—may prevent biphasic reactions but no acute benefit 1

Special Circumstances

Patients on Beta-Blockers:

• Glucagon 1-5 mg IV over 5 minutes, followed by infusion at 5-15 mcg/min 1
• Glucagon bypasses beta-receptor blockade
• Aspiration precautions: Glucagon causes nausea/vomiting 1

Cardiac Arrest from Anaphylaxis:

• Standard CPR/ACLS protocols take priority 2
• High-dose IV epinephrine: 1-3 mg (1:10,000) IV over 3 minutes, then 3-5 mg, then 4-10 mg/min infusion 1
• Pediatric: 0.01 mg/kg (0.1 mL/kg of 1:10,000) every 3-5 minutes 1
• Rapid volume expansion is mandatory 1
• Prolonged resuscitation efforts encouraged—more likely successful in young patients with healthy cardiovascular systems 1

Critical Pitfalls to Avoid

1. Delaying epinephrine while administering antihistamines or steroids—this is the most common fatal error 3, 6
2. Using IV epinephrine prematurely—reserve for true refractory shock after multiple IM doses fail 1
3. Subcutaneous route—inferior to IM injection in the thigh 1
4. Inadequate fluid resuscitation—anaphylactic shock requires large crystalloid volumes due to massive capillary leak 1

Observation and Disposition

• Individualized observation periods required—no reliable predictors of biphasic reactions 1
• Monitor minimum 4-12 hours based on severity and risk factors 6
• Discharge with epinephrine auto-injector and proper training 1
• Arrange allergy/immunology follow-up for trigger identification 1

The evidence consistently demonstrates that prompt IM epinephrine is the only intervention proven to reduce mortality in anaphylactic shock 2, 3, 7. All other medications are adjunctive and should never delay or replace epinephrine administration.